Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Ovid Therapeutics Inc. OVID

Full chart Compare
Set alert

Price alert · OVID

All alert types
2.74 USD +0.34 (+14.17%)

At closeNov 4, 2026, 5:51 PM EST

2.82 +0.08 +2.92%

After hours · Nov 4, 5:51 PM ET

2.38 Day range 2.79
1.18 52-week range 3.11
YTD
+68.10%
1 year
+106.02%

Financial health

Altman Z-Score

11.30 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 5

Valuation

P/E -6.8×
FY 2016: -10.7×FY 2017: -2.9×FY 2018: -1.1×FY 2019: -2.7×FY 2020: -1.7×FY 2021: 1.8×FY 2022: -2.4×FY 2023: -4.4×FY 2024: -2.5×FY 2025: -6.8×
FY 2016 5y median -2.5× FY 2025
P/S 16.6×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 10.7×FY 2021: 1.0×FY 2022: 87.2×FY 2023: 580×FY 2024: 117×FY 2025: 16.6×
FY 2016 5y median 87.2× FY 2025
P/B 0.9×
FY 2016: 4.9×FY 2017: 2.3×FY 2018: 1.5×FY 2019: 2.3×FY 2020: 3.1×FY 2021: 1.2×FY 2022: 1.0×FY 2023: 2.6×FY 2024: 1.0×FY 2025: 0.9×
FY 2016 5y median 1.0× FY 2025
P/FCF -3.1×
FY 2016: -13.3×FY 2017: -6.1×FY 2018: -1.3×FY 2019: -3.2×FY 2020: -2.6×FY 2021: 1.8×FY 2022: -2.3×FY 2023: -4.9×FY 2024: -1.2×FY 2025: -3.1×
FY 2016 5y median -2.3× FY 2025
EV/EBITDA -7.0×
FY 2016: -8.4×FY 2017: -1.6×FY 2018: -0.4×FY 2019: -2.0×FY 2020: -0.8×FY 2021: 0.2×FY 2022: -1.9×FY 2023: -3.8×FY 2024: -0.9×FY 2025: -7.0×
FY 2016 5y median -1.9× FY 2025
EV/Sales 16.6×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 5.0×FY 2021: 0.1×FY 2022: 68.3×FY 2023: 552×FY 2024: 96.6×FY 2025: 16.6×
FY 2016 5y median 68.3× FY 2025
FCF Yield -31.9%
FY 2016: -7.5%FY 2017: -16.5%FY 2018: -77.0%FY 2019: -31.5%FY 2020: -38.5%FY 2021: 54.7%FY 2022: -43.2%FY 2023: -20.2%FY 2024: -84.6%FY 2025: -31.9%
FY 2016 5y median -31.9% FY 2025

Profitability

Gross Margin 95.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 95.9%
FY 2016 5y median 100.0% FY 2025
Operating Margin -585.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -645.4%FY 2021: 59.6%FY 2022: -3696.4%FY 2023: -15122.7%FY 2024: -10933.7%FY 2025: -585.2%
FY 2016 5y median -3696.4% FY 2025
Net Margin -240.1%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -642.3%FY 2021: 58.9%FY 2022: -3604.7%FY 2023: -13351.8%FY 2024: -4670.1%FY 2025: -240.1%
FY 2016 5y median -3604.7% FY 2025
ROE -13.3%
FY 2016: -45.5%FY 2017: -77.7%FY 2018: -134.0%FY 2019: -86.3%FY 2020: -185.7%FY 2021: 68.3%FY 2022: -41.0%FY 2023: -59.6%FY 2024: -38.7%FY 2025: -13.3%
FY 2016 5y median -38.7% FY 2025
ROIC -29.5%
FY 2016: -45.7%FY 2017: -77.8%FY 2018: -136.4%FY 2019: -87.3%FY 2020: -151.2%FY 2021: 68.4%FY 2022: -37.3%FY 2023: -44.3%FY 2024: -74.6%FY 2025: -29.5%
FY 2016 5y median -37.3% FY 2025
ROA -11.5%
FY 2016: -42.3%FY 2017: -72.4%FY 2018: -109.1%FY 2019: -74.8%FY 2020: -106.7%FY 2021: 63.1%FY 2022: -34.9%FY 2023: -36.3%FY 2024: -28.7%FY 2025: -11.5%
FY 2016 5y median -28.7% FY 2025

Growth (YoY)

Revenue 1181.3%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 1551.6%FY 2022: -99.3%FY 2023: -73.9%FY 2024: 44.4%FY 2025: 1181.3%
FY 2016 FY 2025
Operating Income 31.4%
FY 2016: -70.8%FY 2017: -188.5%FY 2018: 18.6%FY 2019: -16.0%FY 2020: -32.6%FY 2021: 252.5%FY 2022: -144.7%FY 2023: -6.7%FY 2024: -4.4%FY 2025: 31.4%
FY 2016 FY 2025
EPS (diluted) 35.1%
FY 2016: -70.1%FY 2017: -193.9%FY 2018: 37.0%FY 2019: 28.4%FY 2020: 7.9%FY 2021: 226.6%FY 2022: -143.8%FY 2023: 3.9%FY 2024: 50.0%FY 2025: 35.1%
FY 2016 FY 2025
Free Cash Flow 31.6%
FY 2016: -224.6%FY 2017: -75.2%FY 2018: -45.7%FY 2019: -11.8%FY 2020: -1.2%FY 2021: 327.8%FY 2022: -147.8%FY 2023: 18.9%FY 2024: -22.0%FY 2025: 31.6%
FY 2016 FY 2025

Financial Health

Current Ratio 10.9×
FY 2016: 14.0×FY 2017: 14.7×FY 2018: 5.0×FY 2019: 7.6×FY 2020: 3.4×FY 2021: 12.9×FY 2022: 18.8×FY 2023: 9.6×FY 2024: 5.3×FY 2025: 10.9×
FY 2016 5y median 10.9× FY 2025
Quick Ratio 10.9×
FY 2016: 14.0×FY 2017: 14.7×FY 2018: 5.0×FY 2019: 7.6×FY 2020: 3.4×FY 2021: 12.9×FY 2022: 18.8×FY 2023: 9.6×FY 2024: 5.3×FY 2025: 10.9×
FY 2016 5y median 10.9× FY 2025
Debt / Equity 0.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.2×FY 2024: 0.2×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -0.0×
FY 2016: 2.3×FY 2017: 1.3×FY 2018: 0.7×FY 2019: 0.7×FY 2020: 0.9×FY 2021: -1.5×FY 2022: 0.5×FY 2023: 0.2×FY 2024: 0.2×FY 2025: -0.0×
FY 2016 5y median 0.2× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31